INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $83,000 | -91.6% | 23,680 | -31.0% | 0.00% | -100.0% |
| Q4 2015 | $983,000 | -39.6% | 34,319 | -40.0% | 0.00% | -33.3% |
| Q3 2015 | $1,628,000 | -25.1% | 57,207 | -5.4% | 0.00% | -25.0% |
| Q2 2015 | $2,173,000 | +47.7% | 60,495 | +139.1% | 0.00% | +33.3% |
| Q1 2015 | $1,471,000 | +11.3% | 25,301 | -19.3% | 0.00% | 0.0% |
| Q4 2014 | $1,322,000 | -14.0% | 31,352 | -20.9% | 0.00% | -25.0% |
| Q3 2014 | $1,538,000 | +25.1% | 39,652 | +0.8% | 0.00% | +33.3% |
| Q2 2014 | $1,229,000 | -24.0% | 39,352 | +0.8% | 0.00% | -40.0% |
| Q1 2014 | $1,618,000 | +118.4% | 39,052 | +104.1% | 0.01% | +150.0% |
| Q4 2013 | $741,000 | – | 19,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |